New combined assessment of chronic obstructive pulmonary disease: Utilization, pitfalls, and association with spirometry

Dua, Ruchi; Kumari, Ranjeeta; Yadav, Vivek; Ranjan, M. Behera; Kumar, Subodh; Mishra, Mayank; Tripathi, Suryakant

doi:10.4103/lungindia.lungindia_163_18

Cited by 3 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Порівняльний аналіз сформованих груп GOLD-2011 і GOLD-2017 виявив як помірну кореляцію між ними [33], так й істотну перекласифікацію хворих від груп C і D до груп A і B відповідно. Так, за GOLD-2011 до груп A, B, C і D було віднесено 29,5, 18,7, 25,4 і 26,3% хворих відповідно, а за GOLD-2017 -48,9, 36,9, 6,0 і 8,4%.…”

Section: наскільки ефективні класифікації фенотипування та ендотипува...unclassified

“…Загальний розподіл тяжчих хворих був зміщений до менш тяжких, що обмежувало обсяг терапії тяжких хворих. Хоча правдивіший розподіл хворих виявився за GOLD-2011, GOLD-2017 надала можливість призначати терапію окремо за оцінкою симптомів або історії хвороби/госпіталізацій [33].…”

Section: наскільки ефективні класифікації фенотипування та ендотипува...unclassified

See 1 more Smart Citation

Наскільки Ефективні Класифікації, Фенотипування Та Ендотипування Хронічного Обструктивного Захворювання Легень Для Вибору Терапевтичної Стратегії?

Форманчук¹

2022

CAMM

View full text Add to dashboard Cite

Section: наскільки ефективні класифікації фенотипування та ендотипува...unclassified

Наскільки Ефективні Класифікації, Фенотипування Та Ендотипування Хронічного Обструктивного Захворювання Легень Для Вибору Терапевтичної Стратегії?

Форманчук¹

2022

CAMM

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease burden, grades and erythrocytosis at a tertiary hospital in western Uganda

Banturaki,

Munyambalu,

Kajoba

et al. 2024

BMC Pulm Med

View full text Add to dashboard Cite

Background Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide among people over 40 years of age, and erythrocytosis is one of the major complications associated with increased mortality among COPD patients. The study aimed to determine the proportion of COPD, associated factors, and the burden of erythrocytosis among COPD participants. Methods and materials A descriptive cross-sectional study design was used. A consecutive sampling technique was used to obtain study participants at the Fort Portal Regional Referral Hospital outpatient clinic. Focused history and physical examination were carried out to select eligible participants. Participants were screened using the COPD population screener for spirometry after consenting to participate. The study enrolled all adults at risk of having COPD based on the COPD population screener and able to undergo spirometry. Spirometry was carried out according to the Global Chronic Obstructive Lung Disease and European Respiratory Society guidelines, and haemoglobin concentration was measured. Results One hundred eighty participants were enrolled in the study, most of whom were females. The modal and mean age of participants was 60 years with 139 (77.2%) females and primary as the highest education level 149(82.8%). The proportion of COPD was 25% (45) [95% CI 18.9 – 32] and highest among females (68.9%) and those aged 60 years and above (70%). The combined COPD assessment tool groups had a proportion of 55.6%, 37.8%, 4.4%, and 2.2% for groups A, B, C, and D, respectively. Age < 50 years was protective against COPD, while for every additional year of smoking, there was an associated 6.5% increased risk compared to the general population. Additionally, the proportion of erythrocytosis among COPD participants was 6.7%. Conclusions and recommendations There was a high proportion of COPD among study participants (25%), with a 6.7% proportion of erythrocytosis. We recommend a complete blood count for every patient in groups C and D of the ABCD COPD GOLD groups.

show abstract

Chronic Obstructive Pulmonary Disease Burden, Grades and Erythrocytosis at a Tertiary Hospital in Western Uganda

Banturaki,

Munyambalu,

Kajoba

et al. 2023

Preprint

View full text Add to dashboard Cite

Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide among people over 40 years of age, and erythrocytosis is one of the major complications associated with increased mortality among COPD patients. Methods and materials: A descriptive cross-sectional study design was used. A consecutive sampling technique was used to obtain study participants at the Fort Portal Regional Referral Hospital outpatient clinic. Focused history and physical examination were carried out to select eligible participants. Participants were screened using the COPD population screener for spirometry after consenting to participate. Spirometry was carried out according to GOLD guidelines, and haemoglobin concentration was measured. Results: A total of 180 participants were enrolled in the study, of whom the majority were females. Thirty-one (68.9%) patients had a modal age of < 50 years and a median age of 60 years. The prevalence of COPD was 25% (45) [95% CI 18.9 – 32] and highest among females (68.9%) and those aged 60 years and above (70%). The combined COPD assessment tool groups had a prevalence of 55.6%, 37.8%, 4.4%, and 2.2% for groups A, B, C, and D, respectively. Age <50 years was protective against COPD, while for every additional year of smoking, there was an associated 6.5% increased risk compared to the general population. Additionally, the prevalence of erythrocytosis among COPD participants was 6.7%. Conclusions and recommendations: There was a high prevalence of COPD among study participants (25%), with a 6.7% prevalence of erythrocytosis. A complete blood count should be performed for every patient with COPD at diagnosis and follow-up.

show abstract

New combined assessment of chronic obstructive pulmonary disease: Utilization, pitfalls, and association with spirometry

Cited by 3 publications

References 13 publications

Наскільки Ефективні Класифікації, Фенотипування Та Ендотипування Хронічного Обструктивного Захворювання Легень Для Вибору Терапевтичної Стратегії?

Наскільки Ефективні Класифікації, Фенотипування Та Ендотипування Хронічного Обструктивного Захворювання Легень Для Вибору Терапевтичної Стратегії?

Chronic obstructive pulmonary disease burden, grades and erythrocytosis at a tertiary hospital in western Uganda

Chronic Obstructive Pulmonary Disease Burden, Grades and Erythrocytosis at a Tertiary Hospital in Western Uganda

Contact Info

Product

Resources

About